Applying Mode-Of-Action And Pharmacokinetic Considerations In The Contempary Cancer Risk Assessments: An Example With Trichloroethylene (Clewell And Andersen, 2004)
Letter to the Editor - response to Clewell and Andersen (2004) [regarding TCE health risk assessment]